GRCE SCHEDULE 13G/A: SEC filing

ADAR1 Capital Management, LLC and related reporting persons

Filed with the SEC on · accession 0001104659-26-128739

GRCE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.1% by the first close after the filing.

Summary of the filing

ADAR1 Capital Management, LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.9% of Grace Therapeutics, Inc.'s common stock, including shares and warrants, as of September 30, 2026.

Key details

Shares of common stock beneficially owned by ADAR1 Capital Management, LLC$2.3M
Shares of common stock beneficially owned by ADAR1 Capital Management GP, LLC$1.9M
Shares of common stock beneficially owned by Daniel Schneeberger$2.3M
Reporting person / investment managerADAR1 Capital Management, LLC
Reporting person / general partnerADAR1 Capital Management GP, LLC
IssuerGrace Therapeutics, Inc.
Manager of adar1 capital management, llc and adar1 capital management gp, llcDaniel Schneeberger

How GRCE stock reacted

Close before

$1.81

Nov 13, 2026

First close after

-1.10%

$1.79

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GRCE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GRCE?

Click here

Frequently asked questions

What did GRCE file with the SEC on Nov 16, 2026?

GRCE filed a SCHEDULE 13G/A (SEC filing). ADAR1 Capital Management, LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 9.9% of Grace Therapeutics, Inc.'s common stock, including shares and warrants, as of September 30, 2026.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did GRCE stock react to this filing?

GRCE closed at $1.81 before the filing and $1.79 on Nov 16, 2026 (-1.10%).

Other GRCE SEC filings

Get alerts when GRCE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days